
|Articles|June 1, 2008
- Pharmaceutical Executive-06-01-2008
- Volume 0
- Issue 0
Suzanne Delaney, AstraZeneca
S
Advertisement
ONE TO WATCH:
Suzanne Delaney, ED, Brand Leader, Breast/Prostate, AstraZeneca
An AZ vet, Delaney directs strategy for four of the drug giant's oncology brands, including Armidex, with over $1.25 billion in global sales last year. She won plaudits from her early days carrying the bag, but once she began managing people, her career really took flight. Her model of leadership is based on authenticity. "I don't think age equates in any way to great leadership," she says.
Articles in this issue
about 18 years ago
Mary Szela, Abbottabout 18 years ago
Mightier Than the Swordabout 18 years ago
Keeshia Muhammad, Teva Specialty Pharmaceuticalsabout 18 years ago
Eric Floyd, Cephalonabout 18 years ago
Nancy Phelan, Wyethabout 18 years ago
Tightening the Chainabout 18 years ago
Kurt Graves, Vertexabout 18 years ago
Wendy Niebler, Shireabout 18 years ago
Perfectly ImperfectAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
Focusing on Asset Acquisition Over Building a Single Platform Technology
5




